The growth of the European intraocular lens market is due to the rising number of ophthalmic disorders and ageing population. The rising prevalence of ocular conditions, such as cataract and diabetic retinopathy across the world, is driving the market’s growth.

Around 34 million people in the European Union (EU) are affected by age-related macular degeneration, as stated by EURETINA, in 2017. Similarly According to the European Society of Retinal Specialists, in 2017, the prevalence rate of age-related macular degeneration was accounted to be approximately 32.8% in Germany.?

Other factors, such as increasing cases of cataract in the diabetic population, is leading to the rising adoption of advanced premium intraocular lens, are likely to propel the growth of the European intraocular lens market. However, the high cost of the intraocular lens and poor reimbursement coverage is expected to hamper the market’s growth during the forecast period.

Key Market Trends

The Toric Intraocular Lens Segment is expected to Experience the Signinficant Rate

Toric intraocular lens is used in cataract surgeries like conventional IOLs, for a couple of important differences like obtaining the measurements prior to surgery, enables the patients to choose the correct lens for getting maximum benefits.?

Toric intraocular lens is available in different powers in different meridians and is used for correcting the asymmetric power of the eye observed in astigmatism.? Toric IOLs are special as they have certain markers on the peripheral parts of the lens to enable the surgeon to see the orientation of the astigmatism correction in the lens. ?The surgeon who performs surgeries using toric lenses can adjust the orientation of the lens to correct astigmatism after the implantation to obtain the best results.?

Furthermore, Toric lens is the most preferred, as it reduces complications during cataract surgeries.? Hence, with the advantages of using toric intraocular lenses, rising ophthalmic issues, and increasing cases of cataracts in the diabetic population, the segment is expected to grow at a good pace during the forecast period.?

Competitive Landscape

The European intraocular lens market is fragmented, due to the presence of numerous market players. Major market players are focusing on partnerships, while signing agreements to enhance their market presence. The major players include Novartis AG (Alcon), Bausch Health Companies Inc. (Bausch + Lomb), Carl Zeiss Meditec AG, EyeKon Medical Inc., Hoya Corporation, HumanOptics AG, Johnson and Johnson Vision Care Inc., Lenstec Inc., Rayner, and STAAR Surgical Company. Furthermore, product innovation and technological advancements are expected to attract new market players.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support